← All algorithms
LAST (Local Anesthetic Systemic Toxicity)
Cardiovascular and CNS toxicity from inadvertent IV injection or systemic absorption of local anesthetic. Bupivacaine highest cardiotoxicity. Ropivacaine + lidocaine slightly safer.
Recognition
- •Early CNS: tinnitus, perioral numbness, metallic taste, agitation
- •Progressive: seizures, LOC
- •Cardiovascular: arrhythmias (especially ventricular), hypotension, asystole
- •Bupivacaine: may go directly to CV collapse without CNS prodrome
Steps
- 1Stop injection. Call for help + lipid emulsion.
- 2Airway management + 100% O₂Hypoxia + acidosis worsen toxicity dramatically.
- 3Lipid Emulsion 20% — bolus 1.5 mL/kg over 1 minRepeat 1–2× if no response. Then infusion 0.25 mL/kg/min.
- 4Modified ACLSAvoid vasopressin. Reduce epi to ≤1 mcg/kg (≤100 mcg). No CCBs, β-blockers, or LA antiarrhythmics.
- 5Treat seizuresBenzodiazepine (midazolam 2–5 mg). Avoid propofol (cardiac depression in unstable patient).
- 6Continue lipid 10 min after stabilityMax ~12 mL/kg lipid (relative limit).
- 7Consider ECMO for refractory cardiac arrestBupivacaine washout takes hours.
- 8Report to LipidRescue.org registry
Drugs + doses
| Drug | Dose | Note |
|---|---|---|
| Lipid Emulsion 20% | 1.5 mL/kg bolus, repeat ×1–2; infusion 0.25 mL/kg/min | |
| Epinephrine | ≤1 mcg/kg (≤100 mcg) IV — much smaller than usual ACLS dose | |
| Midazolam | 2–5 mg IV for seizures |
Pitfalls
- !Standard-ACLS-dose epi worsens bupivacaine arrest — go small.
- !Avoid vasopressin, calcium channel blockers, β-blockers, lidocaine, procainamide.
- !Propofol is NOT a substitute for lipid emulsion (10× too dilute).
Sources
- ASRA 2020 Practice Advisory
- Neal Reg Anesth Pain Med 2018
- AAGBI
Anatomy reference
Sourced reference images. 4 matches for "cardiac sodium channel local anesthetic".
Browse the full image library →Education only — not a substitute for facility protocols, MOC certification, or clinical judgment. Always follow your institutional crisis algorithm and confirm doses against current package inserts.



